伊赫亚,赵秸米,梁晓峰,Teo Yik Ying.新加坡新型冠状病毒疫苗免疫接种策略研究[J].Chinese journal of Epidemiology,2022,43(3):310-314 |
新加坡新型冠状病毒疫苗免疫接种策略研究 |
Research on COVID-19 vaccination strategies in Singapore |
Received:November 25, 2021 |
DOI:10.3760/cma.j.cn112338-20211125-00919 |
KeyWord: 新型冠状病毒 免疫接种 防控措施 新加坡 |
English Key Word: 2019-nCoV Vaccination Prevention and control Singapore |
FundProject:2021年中国科协“一带一路”国际科技组织合作平台建设项目(2021ZZGJB0522) |
Author Name | Affiliation | E-mail | Yi Heya | Chinese Preventive Medicine Association, Beijing 100021, China | | Zhao Jiemi | Chinese Preventive Medicine Association, Beijing 100021, China | | Liang Xiaofeng | Chinese Preventive Medicine Association, Beijing 100021, China Kangtai Biological Vaccine Industry Research Institute, Jinan University, Guangzhou 510632, China | liangxf@just.edu.cn | Teo Yik Ying | National University of Singapore, Singapore City 119077, Singapore | |
|
Hits: 4293 |
Download times: 743 |
Abstract: |
截至2021年12月31日,新加坡累计报告已有4 758 601人完成至少一剂次新型冠状(新冠)病毒疫苗接种,4 714 655人完成两剂次新冠病毒疫苗接种,2 207 341人完成新冠病毒疫苗加强针接种。本研究通过深入分析新加坡新冠病毒疫苗接种现状,解读新加坡国家疫苗接种计划内容,系统梳理新加坡新冠病毒疫苗上门接种、疫苗接种差异化管理、拒绝接种疫苗者感染新冠病毒后自付医药费等具体措施,为我国新冠病毒疫苗接种工作提供参考。 |
English Abstract: |
As of December 31, 2021, Singapore reported that 4 758 601 had completed at least one dose of COVID-19 vaccination, 4 714 655 had completed two doses of COVID-19 vaccination, and 2 207 341 had received one booster shot of COVID-19 vaccine. This article analyses the current performance of COVID-19 vaccination in Singapore, interprets the content of Singapore's National Vaccination Programme, and systematically introduces specific measures of COVID-19 vaccination in Singapore, such as door-to-door vaccination, vaccination differentiated management, and self-payment of medical expenses for those who refuse to be vaccinated, to provide reference for the COVID-19 vaccination in China. |
View Fulltext
Html FullText
View/Add Comment Download reader |
Close |
|
|
|